Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Articles: DFG German National Licenses  (1)
  • C-cell (medullary) carcinoma  (1)
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Langenbeck's archives of surgery 366 (1985), S. 590-590 
    ISSN: 1435-2451
    Keywords: C-cell (medullary) carcinoma ; Tumor recurrence ; Surgical therapy ; C-Zell-Carcinom ; Tumorrezidiv ; Chirurgische Therapie
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Zwischen 1972 und 1984 wurden 25 kurativ operierte Patienten mit C-Zell-Carcinom der Schilddrüse beobachtet. 19 Patienten entwickelten ein Tumorrezidiv. Insgesamt wurden deshalb 40 Rezidivoperationen durchgeführt. Bei fehlenden therapeutischen Alternativen und häufig inadäquater Primärtherapie ist beim Rezidiv ein erneutes chirurgisches Vorgehen erforderlich. Eine Kuration wird durch den Rezidiveingrifisehr selten beobachtet, indiziert ist aber auch eine palliative Tumor- und Metastasenexstirpation. Eine Heilung wird vor allem erreicht durch die frühe Diagnose und einen adäquaten Ersteingriff.
    Notes: Summary Between 1972 and 1984, 25 curatively treated patients with medullary carcinoma of the thyroid gland were observed: 19 of them developed tumor recurrence. Altogether, there were 40 reoperations performed. Because there are no therapeutic alternatives and primary treatment is often unsatisfactory, further surgical procedures are required. Very rarely is a cure observed by secondary operation, but palliative tumor and metastasis extirpation is also indicated. A cure is mostly obtained by early diagnosis and adequate primary operation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...